Rosuvastatin Only Minimally Effective in Reducing AF in Patients with HF

Aldo Maggioni

doi:10.1177/155989770904013

Related publications

Article2009

Effect of n-3 polyunsaturated fatty acids and rosuvastatin in patients with heart failure: results of the GISSI-HF trial

Roberto Marchioli, Giacomo Levantesi, Maria G Silletta, Simona Barlera, Marino Bernardinangeli, Emanuele Carbonieri, Francesco Cosmi, Maria Grazia Franzosi, Roberto Latini, Donata Lucci, Aldo Maggioni, Luciano Moretti, Gian Luigi Nicolosi, Maurizio Porcu, Maria Grazia Rossi, Gianni Tognoni, Luigi Tavazzi

Article2018

Rosuvastatin use improves measures of coagulation in patients with venous thrombosis

Joseph S. Biedermann, Marieke J.H.A. Kruip, Felix J. van der Meer, Frits R. Rosendaal, Frank W.G. Leebeek, Suzanne C. Cannegieter, Willem M. Lijfering

European Heart Journal

Article2017

INCREASED RATE OF PREVIOUS STROKE IN ASYMPTOMATIC/MINIMALLY SYMPTOMATIC VERSUS SYMPTOMATIC PATIENTS WITH NEWLY DETECTED ATRIAL FIBRILLATION WORLDWIDE: RESULTS FROM THE GLORIA-AF REGISTRY

Steffen P. Christow, Karlheinz Seidl, Hans‐Christoph Diener, Menno V. Huisman, Professor Gregory Lip, Ursula Rauch-Kroenert, Stefan Schuster, Johannes Brachmann, A. Muegge, Peter Schwimmbeck, Christine Teutsch, Jochen Senges

Article2009

Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis

Bengt Fellström, Alan G. Jardine, Roland E. Schmieder, Hallvard Holdaas, Kym M. Bannister, Jaap J. Beutler, Dong‐Wan Chae, Alejandro Chevaile, Stuart M. Cobbe, Carola Grönhagen‐Riska, José J. De Lima, R. Lins, Gert Mayer, Alan W. McMahon, Hans‐Henrik Parving, Giuseppe Remuzzi, Ola Samuelsson, S. Sonkodi, Gültekin Süleymanlar, Dimitrios Tsakiris, Vladimı́r Tesař, Vasil Todorov, Andrzej Więcek, Rudolf P. Wüthrich,

Article2007

Rosuvastatin: The Most Efficient Treatment Option For Patients With Dyslipidemia

Jaakko Tuomilehto

Future Lipidology